Share on StockTwits

ResMed (NYSE:RMD) COO Robert Andrew Douglas sold 8,000 shares of the stock on the open market in a transaction that occurred on Friday, August 1st. The shares were sold at an average price of $48.95, for a total transaction of $391,600.00. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

A number of analysts have recently weighed in on RMD shares. Analysts at Piper Jaffray cut their price target on shares of ResMed from $55.00 to $53.00 in a research note on Friday. Separately, analysts at Canaccord Genuity cut their price target on shares of ResMed from $43.00 to $39.00 in a research note on Friday. Finally, analysts at Jefferies Group reiterated a “hold” rating on shares of ResMed in a research note on Friday. They now have a $42.00 price target on the stock, up previously from $40.00. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $46.01.

Shares of ResMed (NYSE:RMD) traded up 0.08% during mid-day trading on Tuesday, hitting $49.41. The stock had a trading volume of 821,029 shares. ResMed has a one year low of $41.52 and a one year high of $57.34. The stock has a 50-day moving average of $50.59 and a 200-day moving average of $47.77. The company has a market cap of $6.944 billion and a P/E ratio of 20.66.

ResMed (NYSE:RMD) last released its earnings data on Thursday, July 31st. The company reported $0.64 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.66 by $0.02. The company had revenue of $415.20 million for the quarter, compared to the consensus estimate of $433.42 million. During the same quarter last year, the company posted $0.62 earnings per share. ResMed’s revenue was up .1% compared to the same quarter last year. Analysts expect that ResMed will post $2.56 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which is scheduled for Thursday, September 18th. Investors of record on Thursday, August 21st will be given a dividend of $0.28 per share. This represents a $1.12 dividend on an annualized basis and a yield of 2.27%. The ex-dividend date of this dividend is Tuesday, August 19th. This is an increase from ResMed’s previous quarterly dividend of $0.25.

ResMed Inc, (NYSE:RMD) is a holding company for the ResMed Group.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.